Kenneth Hensley

Dr. Kenneth Hensley


Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2012 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
BSBranden Stansley
Branden Stansley
JPJan Post
Jan Post
KHKenneth Hensley
Kenneth Hensley
Over the past two decades, it has become increasingly apparent that Alzheimer’s disease neuropathology is characterized by activated microglia (brain resident macrophages) as well as the classic features of amyloid plaques and neurofibrillary tangles. The intricacy of microglial biology has also become apparent, leading to a heightened research interest in this particular cell type. Over the years a number of different microglial cell culturing techniques have been developed to study either primary mammalian microglia, or immortalized cell lines. Each microglial system has advantages and disadvantages and should be selected for its appropriateness in a particular research context. This review summarizes several of the most common microglial cell culture systems currently being employed in Alzheimer’s research including primary microglia; BV2 and N9 retroviral immortalized microglia; human immortalized microglia (HMO6); and spontaneously immortalized rodent microglial lines (EOC lines and HAPI cells). Particularities of cell culture requirements and characteristics of microglial behavior, especially in response to applied inflammogen stimuli, are compared and discussed across these cell types.

8 July 2010 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
KHKenneth Hensley
Kenneth Hensley
The concept of neuroinflammation has evolved over the past two decades from an initially controversial viewpoint to its present status as a generally accepted idea whose mechanisms and consequences are still actively under research and debate, partic

28 January 2011 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
KHKenneth Hensley
Kenneth Hensley
KVKalina Venkova
Kalina Venkova
ACAlexandar Christov
Alexandar Christov
WGWilliam Gunning
William Gunning
JPJoshua Park
Joshua Park

22 June 2016 in Journal of Alzheimer’s Disease
Verified
Journal Article
Open access
PDF file
KHKenneth Hensley
Kenneth Hensley
PKPetri Kursula
Petri Kursula
Alzheimer’s disease (AD) has long been viewed as a pathology that must be caused either by aberrant amyloid-β protein precursor (AβPP) processing, dysfunctional tau protein processing, or a combination of these two factors. This is a reasonable assum

24 February 2010 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
KHKenneth Hensley
Kenneth Hensley
ACAlexandar Christov
Alexandar Christov
SKShekhar Kamat
Shekhar Kamat
XZX. Cai Zhang
X. Cai Zhang
KJKenneth W. Jackson
Kenneth W. Jackson
JPJan Post
Jan Post
Lanthionine ketimine (LK) represents a poorly understood class of thioethers present in mammalian CNS. Previous work has indicated high-affinity interaction of LK with synaptosomal membrane protein(s), but neither LK binding partners nor specific bioactivities have been reported. In this study, LK was chemically synthesized and used as an affinity agent to capture binding partners from mammalian brain lysate. Liquid chromatography with electrospray ionization–mass spectrometry of electrophoretically separated, LK-bound proteins identified polypeptides implicated in axon remodeling or vesicle trafficking and diseases including Alzheimer's disease and schizophrenia: collapsin response mediator protein-2/dihydropyrimidinase-like protein-2 (CRMP2/DRP2/DPYSL2), myelin basic protein, and syntaxin-binding protein-1 (STXBP1/Munc-18). Also identified was the recently discovered glutathione-binding protein lanthionine synthetase-like protein-1. Functional consequences of LK:CRMP2 interactions were probed through immunoprecipitation studies using brain lysate wherein LK was found to increase CRMP2 coprecipitation with its partner neurofibromin-1 but decreased CRMP2 coprecipitation with β-tubulin. Functional studies of NSC-34 motor neuron-like cells indicated that a cell-permeable LK-ester, LKE, was nontoxic and protective against oxidative challenge with H2O2. LKE-treated NSC-34 cells significantly increased neurite number and length in a serum concentration-dependent manner, consistent with a CRMP2 interaction. Finally, LKE antagonized the activation of EOC-20 microglia by inflammogens. The results are discussed with reference to possible biochemical origins, paracrine functions, neurological significance, and pharmacological potential of lanthionyl compounds.

1 December 2015 in Neurobiology of Disease
Verified
Journal Article
Closed access
KHKenneth Hensley
Kenneth Hensley
MHMarni E. Harris-White
Marni E. Harris-White